Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
PCSK9 Inhibitors: Bloodwork Guide
Recommended lab tests and biomarkers to monitor before, during, and after PCSK9 Inhibitors therapy. Testing schedules are based on clinical protocols and published monitoring guidelines.
Back to PCSK9 Inhibitors overviewBefore Starting (1 test)
| Biomarker | Expected Effect | Retest |
|---|---|---|
| ALT/AST | → normalizes | Every 12 weeks |
During Treatment (3 tests)
| Biomarker | Expected Effect | Retest |
|---|---|---|
| LDL Cholesterol | ↓ decreases | Every 8 weeks |
| Total Cholesterol | ↓ decreases | Every 12 weeks |
| Lipoprotein(a) | ↓ decreases | Every 12 weeks |